Posts

Showing posts from January, 2021

Global Respiratory Care Devices Market will be US$ 30.5 Billion by 2025

Image
According to the latest report by Renub Research, titled " Respiratory Care Devices Market Global Analysis by Product, Type, Region, Companies " captures a detailed analysis of the Respiratory Care Devices Market. The market for respiratory care devices will grow in the upcoming years. This market's growth is mainly due to the high prevalence of respiratory diseases, the growing ageing population worldwide, the high prevalence of smoking, the increasing level of urbanization and pollution, the increasing incidence of preterm births, and changes in lifestyles. There is a sudden growth in the demand for respiratory treatment products due to the global outbreak of the coronavirus. By 2025, the Respiratory Care Devices Market will be US$ 30.5 billion, according to Renub Research report. Nevertheless, a lack of knowledge leading to a significant undiagnosed and untreated population and the damaging impact on some respiratory care devices' neonates have hampered market gro

Global Continuous Glucose Monitoring Market will be USD 5.6 Billion by 2025

Image
According to the latest report by Renub Research, titled " Continuous Glucose Monitoring (CGM) Market, Users, Reimbursement Policy, Global Analysis, CGM Components Market, Diabetes (Type1 & 2) Population, & Forecast " captures a detailed analysis of the CGM Market. The numbers of diabetic patients are increasing year on year. Therefore the market of monitoring devices is also growing, according to Renub Research analysis, the Global CGM Market will be US$ 5.6 Billion by the year 2025. CGM is an essential device that offers real-time information on blood glucose levels and helps find a detailed blood glucose level pattern within 24 hours (288 reading). CGM gives Real-time reading every five minutes. Besides, since patients do not need to poke their finger, CGM is better than glucose-meter. For patients with daily hypoglycemia and hyperglycemia and glycemic targets, CGM is recommended. Continuous glucose monitoring (CGM) offers dynamic information about the path of glu